Riskpilot← Back to searchSign inGet full accessMedAdel AB
ABActiveOrg 5564722865Prinsgatan 12 Vån 6Medical specialists activities · NACE 8622Est. 19937 employees
Revenue 2024
SEK 20,8M
+5% vs 2023
EBITDA margin
42.9%
-6% vs 2023
Equity ratio
84.9%
Financial strength
Net profit 2024
SEK 6,8M
-3% vs 2023
| Revenue | SEK 20,8M | +5% |
| EBITDA | SEK 8,9M | -6% |
| Net profit | SEK 6,8M | -3% |
| Total assets | SEK 17,7M | +21% |
| Equity | SEK 15M | +83% |
| Employees | 7 | — |
Legal name
MedAdel AB
Org number
5564722865
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
30 augusti 1993
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är läkarverksamhet, medicinsk dataverksamhet, handelsagentur för läkemedel och handel med värdepapper och därmed förenlig verksamhet.
Address
Prinsgatan 12 Vån 6
Phone
+46703403444
Email
admin@adelspecialistklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 5 675 | 14 475 | 14 598 | 18 444 | 17 923 | 19 856 | 20 845 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −1 529 |
| EBITDA | 2 521 | 3 354 | 3 352 | −467 | 5 503 | 4 603 | 6 890 | 6 268 | 9 454 | 8 933 |
| Depreciation & amort. | −1 314 | −984 | −455 | −1 540 | −590 | −462 | −318 | −181 | −664 | −522 |
| EBIT | 1 207 | 2 370 | 2 897 | −2 007 | 4 913 | 4 141 | 6 572 | 6 087 | 8 790 | 8 411 |
| Net financials | 299 | 96 | −44 | −2 681 | 2 022 | 225 | −2 | 8 | 51 | 184 |
| Profit before tax | 1 506 | 2 466 | 2 853 | 312 | 6 935 | 4 366 | 6 570 | 6 096 | 8 840 | 8 595 |
| Tax | −333 | −486 | −647 | −674 | −1 013 | −938 | −1 371 | −1 259 | −1 823 | −1 774 |
| Net profit | 1 173 | 1 980 | 2 206 | −362 | 5 922 | 3 428 | 5 199 | 4 837 | 7 017 | 6 821 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9 377 | 10 345 | 11 479 | 9 700 | 15 855 | 17 691 | 22 325 | 7 727 | 14 566 | 17 665 |
| Equity | 8 013 | 9 093 | 10 299 | 8 437 | 13 885 | 15 713 | 20 102 | 5 155 | 8 173 | 14 993 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 1 194 | 1 252 | 1 180 | 1 263 | 1 970 | 1 978 | 2 223 | 2 572 | 6 394 | 2 671 |
| Total debt | 1 194 | 1 252 | 1 180 | 1 263 | 1 970 | 1 978 | 2 223 | 2 572 | 6 394 | 2 671 |
EBITDA margin
42.9%
This company
15.8%
Market median
+172% vs market
20152024
Equity ratio
84.9%
This company
38.2%
Market median
+122% vs market
20152024
Return on equity
45.5%
This company
18.4%
Market median
+147% vs market
20152024
Net profit margin
32.7%
This company
8.1%
Market median
+304% vs market
20152024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20152024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JJ Chief Auditor | Chief Auditor | 2021 | — | — |
LG Audit | Audit | 2021 | — | — |
RE Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Upnorth AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Upnorth AB
MedAdel AB Board members of MedAdel AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Jörgen Nilsson | Chief Auditor | 0 companies |
| Lars Gösta Ekeståhl | Audit | 0 companies |
| Robert Erik Viklund | Chief Auditor | 0 companies |
| Paulina Victoria Gillblad Jacobsson | Deputy Board Member | 0 companies |
| Adel Haghjoo | Board of Directors | 0 companies |
| Peter Olof Ramin Haghjoo | Chairman | 0 companies |